115 related articles for article (PubMed ID: 8049236)
1. Substrate-dependent mechanisms in the catalysis of human immunodeficiency virus protease.
Polgár L; Szeltner Z; Boros I
Biochemistry; 1994 Aug; 33(31):9351-7. PubMed ID: 8049236
[TBL] [Abstract][Full Text] [Related]
2. Rate-determining steps in HIV-1 protease catalysis. The hydrolysis of the most specific substrate.
Szeltner Z; Polgár L
J Biol Chem; 1996 Dec; 271(50):32180-4. PubMed ID: 8943273
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus-1 protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism.
Hyland LJ; Tomaszek TA; Meek TD
Biochemistry; 1991 Aug; 30(34):8454-63. PubMed ID: 1883831
[TBL] [Abstract][Full Text] [Related]
4. Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates.
Weber IT; Wu J; Adomat J; Harrison RW; Kimmel AR; Wondrak EM; Louis JM
Eur J Biochem; 1997 Oct; 249(2):523-30. PubMed ID: 9370363
[TBL] [Abstract][Full Text] [Related]
5. Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites.
Griffiths JT; Phylip LH; Konvalinka J; Strop P; Gustchina A; Wlodawer A; Davenport RJ; Briggs R; Dunn BM; Kay J
Biochemistry; 1992 Jun; 31(22):5193-200. PubMed ID: 1606143
[TBL] [Abstract][Full Text] [Related]
6. Effect of substrate residues on the P2' preference of retroviral proteinases.
Boross P; Bagossi P; Copeland TD; Oroszlan S; Louis JM; Tözsér J
Eur J Biochem; 1999 Sep; 264(3):921-9. PubMed ID: 10491141
[TBL] [Abstract][Full Text] [Related]
7. Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease.
Tomaszek TA; Moore ML; Strickler JE; Sanchez RL; Dixon JS; Metcalf BW; Hassell A; Dreyer GB; Brooks I; Debouck C
Biochemistry; 1992 Oct; 31(42):10153-68. PubMed ID: 1420138
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic studies on the human matrix metalloproteinase stromelysin.
Harrison RK; Chang B; Niedzwiecki L; Stein RL
Biochemistry; 1992 Nov; 31(44):10757-62. PubMed ID: 1420192
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
[TBL] [Abstract][Full Text] [Related]
10. Activity of tethered human immunodeficiency virus 1 protease containing mutations in the flap region of one subunit.
Tözsér J; Yin FH; Cheng YS; Bagossi P; Weber IT; Harrison RW; Oroszlan S
Eur J Biochem; 1997 Feb; 244(1):235-41. PubMed ID: 9063469
[TBL] [Abstract][Full Text] [Related]
11. Mutational, kinetic, and NMR studies of the mechanism of E. coli GDP-mannose mannosyl hydrolase, an unusual Nudix enzyme.
Legler PM; Massiah MA; Mildvan AS
Biochemistry; 2002 Sep; 41(35):10834-48. PubMed ID: 12196023
[TBL] [Abstract][Full Text] [Related]
12. Substrate specificity of glutaminyl cyclases from plants and animals.
Schilling S; Manhart S; Hoffmann T; Ludwig HH; Wasternack C; Demuth HU
Biol Chem; 2003 Dec; 384(12):1583-92. PubMed ID: 14719800
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus-1 protease. 1. Initial velocity studies and kinetic characterization of reaction intermediates by 18O isotope exchange.
Hyland LJ; Tomaszek TA; Roberts GD; Carr SA; Magaard VW; Bryan HL; Fakhoury SA; Moore ML; Minnich MD; Culp JS
Biochemistry; 1991 Aug; 30(34):8441-53. PubMed ID: 1883830
[TBL] [Abstract][Full Text] [Related]
14. Unusual secondary specificity of prolyl oligopeptidase and the different reactivities of its two forms toward charged substrates.
Polgár L
Biochemistry; 1992 Aug; 31(33):7729-35. PubMed ID: 1510958
[TBL] [Abstract][Full Text] [Related]
15. Conformational stability and catalytic activity of HIV-1 protease are both enhanced at high salt concentration.
Szeltner Z; Polgár L
J Biol Chem; 1996 Mar; 271(10):5458-63. PubMed ID: 8621402
[TBL] [Abstract][Full Text] [Related]
16. Site-directed mutagenesis of the active site glutamate in human matrilysin: investigation of its role in catalysis.
Cha J; Auld DS
Biochemistry; 1997 Dec; 36(50):16019-24. PubMed ID: 9398337
[TBL] [Abstract][Full Text] [Related]
17. Kinetic and mechanistic studies of penicillin-binding protein 2x from Streptococcus pneumoniae.
Thomas B; Wang Y; Stein RL
Biochemistry; 2001 Dec; 40(51):15811-23. PubMed ID: 11747459
[TBL] [Abstract][Full Text] [Related]
18. Sensitive, soluble chromogenic substrates for HIV-1 proteinase.
Richards AD; Phylip LH; Farmerie WG; Scarborough PE; Alvarez A; Dunn BM; Hirel PH; Konvalinka J; Strop P; Pavlickova L
J Biol Chem; 1990 May; 265(14):7733-6. PubMed ID: 2186027
[TBL] [Abstract][Full Text] [Related]
19. Substitutions at the P2' site of gag p17-p24 affect cleavage efficiency by HIV-1 protease.
Margolin N; Heath W; Osborne E; Lai M; Vlahos C
Biochem Biophys Res Commun; 1990 Mar; 167(2):554-60. PubMed ID: 2182016
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic studies on thrombin catalysis.
Stone SR; Betz A; Hofsteenge J
Biochemistry; 1991 Oct; 30(41):9841-8. PubMed ID: 1911776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
